Effects of dopamine and glutamate on synaptic plasticity: A computational modeling approach for drug abuse as comorbidity in mood disorders

Pharmacopsychiatry

Volumn 44, Issue SUPPL. 1, 2011, Pages

  Qi, Z ^a,b   Kikuchi, S ^a,b   Tretter, F ^c   Voit, E O ^a,b,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c KLINIKUM MÜNCHEN OST   (Germany)

^d Klinikum München Ost ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AMPHETAMINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; ECOPIPAM; GLUTAMIC ACID; PHOSPHODIESTERASE; PHOSPHOPROTEIN DARPP 32;

ARTICLE; COMORBIDITY; DOPAMINERGIC SYSTEM; DRUG ABUSE; GABAERGIC SYSTEM; HUMAN; MAJOR DEPRESSION; MATHEMATICAL MODEL; MOOD DISORDER; MOTIVATION; NERVE CELL; NERVE CELL PLASTICITY; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REWARD; SECOND MESSENGER; SIGNAL TRANSDUCTION; SIMULATION; STRESS;

AMPHETAMINE; COMORBIDITY; COMPUTER SIMULATION; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; GABAERGIC NEURONS; GLUTAMIC ACID; HUMANS; MOOD DISORDERS; NEURONAL PLASTICITY; NEUROTRANSMITTER AGENTS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS;

EID: 79955691455     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0031-1273707     Document Type: Article

References (78)

1. APA. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR Fourth Edition; Text Revision). Washington, DC Americal Psychiatric Association 2000
2. Barbano PE, Spivak M, Flajolet M et al,. A mathematical tool for exploring the dynamics of biological networks. Proc Natl Acad Sci USA 2007 104 19169-19174
3. Bewernick BH, Hurlemann R, Matusch A et al,. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010 67 110-116
4. Bhalla US, Iyengar R. Emergent properties of networks of biological signaling pathways. Science 1999 283 381-387
5. Bibb JA, Snyder GL, Nishi A et al,. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 1999 402 669-671 (Pubitemid 129516337)
6. Calabresi P, Centonze D, Gubellini P et al,. Glutamate-triggered events inducing corticostriatal long-term depression. J Neurosci 1999 19 6102-6110 (Pubitemid 29327942)
7. Calabresi P, Pisani A, Mercuri NB et al,. Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels. Eur J Neurosci 1992 4 929-935
8. Castellani GC, Bazzani A, Cooper LN. Toward a microscopic model of bidirectional synaptic plasticity. Proc Natl Acad Sci USA 2009 106 14091-14095
9. Conner KR, Pinquart M, Holbrook AP. Meta-analysis of depression and substance use and impairment among cocaine users. Drug Alcohol Depend 2008 98 13-23
10. Dackis CA, Gold MS, Sweeney DR. The physiology of cocaine craving and crashing Arch Gen Psychiatry 1987 44 298-300
11. Desdouits F, Cheetham JJ, Huang HB et al,. Mechanism of inhibition of protein phosphatase 1 by DARPP-32: studies with recombinant DARPP-32 and synthetic peptides. Biochem Biophys Res Commun 1995 206 652-658
12. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988 85 5274-5278
13. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008 213 93-118
14. Fernandez É, Schiappa R, Girault JA et al,. DARPP-32 is a robust integrator of dopamine and glutamate signals. PLoS Comput Biol 2006 2 e176
15. Gaiarsa JL, Caillard O, Ben-Ari Y. Long-term plasticity at GABAergic and glycinergic synapses: mechanisms and functional significance. Trends Neurosci 2002 25 564-570 (Pubitemid 35254180)
16. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry 1986 43 107-113 (Pubitemid 16163529)
17. Girault JA, Hemmings HC Jr, Williams KR et al,. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II. J Biol Chem 1989 264 21748-21759 (Pubitemid 20028744)
18. Hayer A, Bhalla US. Molecular switches at the synapse emerge from receptor and kinase traffic. PLoS Comput Biol 2005 1 137-154
19. Hemmings HC Jr, Greengard P. DARPP-32, a dopamine- and adenosine 3:5-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution. J Neurosci 1986 6 1469-1481 (Pubitemid 16078034)
20. Hemmings HC Jr, Nairn AC, Greengard P. DARPP-32, a dopamine- and adenosine 3:5-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1. J Biol Chem 1984 259 14491-14497 (Pubitemid 15222269)
21. Hofmann F, Bechtel PJ, Krebs EG. Concentrations of cyclic AMP-dependent protein kinase subunits in various tissues. J Biol Chem 1977 252 1441-1447 (Pubitemid 8047752)
22. Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001 2 695-703 (Pubitemid 33674815)
23. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006 29 565-598 (Pubitemid 44476856)
24. Janowsky DS, Overstreet DH. The role of acetylcholine mechanisms in mood disorders. In: Bloom FE, Kupfer DJ eds, Psychopharmacology: The fourth generation of progress. New York Raven Press, Ltd 1995 xlii+2002
25. Kauer JA. Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol 2004 66 447-475 (Pubitemid 40614451)
26. Kessler RC, Berglund P, Demler O et al,. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama 2003 289 3095-3105 (Pubitemid 37432885)
27. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985 142 1259-1264 (Pubitemid 16216560)
28. Kim M, Huang T, Abel T et al,. Temporal sensitivity of protein kinase a activation in late-phase long term potentiation. PLoS Comput Biol 2010 6 e1000691
29. Koob GF, Kenneth Lloyd G, Mason BJ. Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nat Rev Drug Discov 2009 8 500-515
30. Krystal JH. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants. Arch Gen Psychiatry 2010 67 1110-1111
31. Lindskog M, Kim M, Wikstrom MA et al,. Transient calcium and dopamine increase PKA activity and DARPP-32 phosphorylation. PLoS Comput Biol 2006 2 e119
32. Luscher B, Shen Q, Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 2010
33. Maletic V, Robinson M, Oakes T et al,. Neurobiology of depression: an integrated view of key findings. International journal of clinical practice 2007 61 2030-2040 (Pubitemid 350077413)
34. Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998 18 135-174 (Pubitemid 28062580)
35. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997 9 471-481 (Pubitemid 27363950)
36. Mayberg HS. Defining the neural circuitry of depression: Strategies toward treatment selection based on neuroimaging phenotypes. Psychiatric Annals 2006 36 259-268
37. Mayberg HS. Targeted electrode-based modulation of neural circuits for depression. J Clin Invest 2009 119 717-725
38. Monk CS, Klein RG, Telzer EH et al,. Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. Am J Psychiatry 2008 165 90-98 (Pubitemid 351704557)
39. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997 349 1436-1442 (Pubitemid 27212192)
40. Nagase T, Murakami T, Nozaki H et al,. Tissue and subcellular distributions, and characterization of rat brain protein phosphatase 2A containing a 72-kDa delta/B subunit. J Biochem 1997 122 178-187 (Pubitemid 27346237)
41. Nakano T, Doi T, Yoshimoto J et al,. A kinetic model of dopamine- and calcium-dependent striatal synaptic plasticity. PLoS Comput Biol 2010 6 e1000670
42. Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006 59 1151-1159 (Pubitemid 44192421)
43. Nishi A, Bibb JA, Snyder GL et al,. Amplification of dopaminergic signaling by a positive feedback loop. Proc Natl Acad Sci USA 2000 97 12840-12845
44. Ouimet CC, da Cruz e Silva EF, Greengard P. The alpha and gamma 1 isoforms of protein phosphatase 1 are highly and specifically concentrated in dendritic spines. Proc Natl Acad Sci USA 1995 92 3396-3400
45. Patel S, Morris SA, Adkins CE et al,. Ca2+-independent inhibition of inositol trisphosphate receptors by calmodulin: redistribution of calmodulin as a possible means of regulating Ca2+ mobilization. Proc Natl Acad Sci USA 1997 94 11627-11632
46. Pelizza L, Ferrari A. Anhedonia in schizophrenia and major depression: state or trait? Ann Gen Psychiatry 2009 8 22
47. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010 35 192-216
48. Qi Z, Miller GW, Voit EO. Computational systems analysis of dopamine metabolism. PLoS One 2008 3 e2444
49. Qi Z, Miller GW, Voit EO. A mathematical model of presynaptic dopamine homeostasis: implications for schizophrenia. Pharmacopsychiatry 2008 41 Suppl. 1 S89-S98
50. Qi Z, Miller GW, Voit EO. The internal state of medium spiny neurons varies in response to different input signals. BMC Syst Biol 2010 4 26
51. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006 27 24-31 (Pubitemid 43083561)
52. Rakhilin SV, Olson PA, Nishi A et al,. A network of control mediated by regulator of calcium/calmodulin-dependent signaling. Science 2004 306 698-701 (Pubitemid 39440920)
53. Rao U, Hammen CL, Poland RE. Mechanisms underlying the comorbidity between depressive and addictive disorders in adolescents: interactions between stress and HPA activity. The American journal of psychiatry 2009 166 361-369
54. Rayport SG, Kandel ER. Development of plastic mechanisms related to learning at identified chemical synaptic connections in Aplysia. Neuroscience 1986 17 283-294 (Pubitemid 16128792)
55. Reynolds JN, Hyland BI, Wickens JR. A cellular mechanism of reward-related learning. Nature 2001 413 67-70 (Pubitemid 32843488)
56. Reynolds JN, Wickens JR. Substantia nigra dopamine regulates synaptic plasticity and membrane potential fluctuations in the rat neostriatum, in vivo. Neuroscience 2000 99 199-203 (Pubitemid 30628407)
57. Reynolds JN, Wickens JR. Dopamine-dependent plasticity of corticostriatal synapses. Neural Netw 2002 15 507-521 (Pubitemid 34947461)
58. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 1988 45 1023-1031 (Pubitemid 18261765)
59. Ross HE, Glasser FB, Stiasny S. Sex differences in the prevalence of psychiatric disorders in patients with alcohol and drug problems. Br J Addict 1988 83 1179-1192 (Pubitemid 19000752)
60. Sanacora G, Mason GF, Rothman DL et al,. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999 56 1043-1047 (Pubitemid 29526389)
61. Sanderson WC, Beck AT, Beck J. Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships. Am J Psychiatry 1990 147 1025-1028 (Pubitemid 20257514)
62. Shi SH, Hayashi Y, Petralia RS et al,. Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science 1999 284 1811-1816
63. Sim AT, Ratcliffe E, Mumby MC et al,. Differential activities of protein phosphatase types 1 and 2A in cytosolic and particulate fractions from rat forebrain. J Neurochem 1994 62 1552-1559
64. Snyder GL, Allen PB, Fienberg AA et al,. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J Neurosci 2000 20 4480-4488 (Pubitemid 30396613)
65. Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 3rdedition ed: Cambridge University Press 2008 1132
66. Sulzer D, Sonders MS, Poulsen NW et al,. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005 75 406-433 (Pubitemid 40834286)
67. Takahashi S, Ohshima T, Cho A et al,. Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc Natl Acad Sci USA 2005 102 1737-1742 (Pubitemid 40209237)
68. Tang K, Low MJ, Grandy DK et al,. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci USA 2001 98 1255-1260 (Pubitemid 32121219)
69. Tisch S, Silberstein P, Limousin-Dowsey P et al,. The basal ganglia: anatomy, physiology, and pharmacology. Psychiatr Clin North Am 2004 27 757-799 (Pubitemid 39535128)
70. Usui H, Inoue R, Tanabe O et al,. Activation of protein phosphatase 2A by cAMP-dependent protein kinase-catalyzed phosphorylation of the 74-kDa B (delta) regulatory subunit in vitro and identification of the phosphorylation sites. FEBS Lett 1998 430 312-316 (Pubitemid 28337935)
71. Voit EO. Computational analysis of biochemical systems: a practical guide for biochemists and molecular biologists. Cambridge, UK Cambridge University Press 2000 xii, 531 p.
72. Voit EO, Qi Z, Miller GW. Steps of modeling complex biological systems. Pharmacopsychiatry 2008 41 Suppl. 1 S78-S84
73. Weiss RD, Mirin SM, Griffin ML. Methodological considerations in the diagnosis of coexisting psychiatric disorders in substance abusers. Br J Addict 1992 87 179-187
74. Wickens JR, Begg AJ, Arbuthnott GW. Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro. Neuroscience 1996 70 1-5 (Pubitemid 126755219)
75. Willner P. Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res 1983 287 211-224 (Pubitemid 14213761)
76. Willner P. Dopamine and depression: a review of recent evidence. II. Theoretical approaches. Brain Res 1983 287 225-236
77. Willner P. Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments. Brain Res 1983 287 237-246 (Pubitemid 14213763)
78. Zetterstrom T, Sharp T, Ungerstedt U. Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Eur J Pharmacol 1986 132 1-9 (Pubitemid 17229963)